Sage Journals: Discover world-class research

Abstract

Modafinil is a wakefulness-promoting agent that is known to be used off-label as a cognitive enhancer and for the treatment of attention deficit hyperactivity disorder (ADHD).¹ There are increasing case reports of Modafinil-induced psychosis; however, this is the first to report a patient with ADHD to develop psychosis from Modafinil use.

Keywords

Modafinil psychosis attention deficit hyperactivity disorder

Get full access to this article

View all access options for this article.

References

Therapeutic Goods Administration. Australian Public Assessment Report for Armodafinil, https://www.tga.gov.au/sites/default/files/auspar-armodafinil-160526.pdf (2016, accessed 10 March 2020).

Lachenmeier

Habel

Fischer

, et al. Are side effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination? F1000Research 2019; 8: 1394.

Modafinil-induced psychosis in a patient with attention deficit hyperactivity disorder

Abstract

Keywords

Get full access to this article

References